Recruiting
Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma
NCT06558604
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Az Sint-Jan Brugge - Oostende Av Bruges, Belgium
- Institut Jules Bordet Brussels, Belgium
- Chu de Liege Liège, Belgium
- Chu Ucl Namur - Site Godinne Yvoir, Belgium